Novo Nordisk to launch lower-cost Ozempic copy in South Africa
The move puts a company-made cheaper semaglutide version into a market where access has been limited by price.
MH
By Maren Holt · Senior Reporter, GLP-1
Jul 17 03:00 ETSource: Reuters
The wire
- 01Novo Nordisk plans to launch a lower-cost copy of its semaglutide product Ozempic in South Africa, Reuters reports.
- 02Pricing moves in emerging markets shape global semaglutide supply and set reference points for access debates elsewhere.
- 03Launch timing, price level and volume commitments were not detailed in the report.
From the source
Read at reuters.comNovo Nordisk to launch lower-cost Ozempic copy in South Africa